ClinicalTrials.Veeva

Menu

The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection.

K

Karolinska University Hospital

Status

Completed

Conditions

Bile Leakage

Treatments

Device: Transpapillary plastic stent (7-10 Fr)

Study type

Interventional

Funder types

Other

Identifiers

NCT01960712
2006/1142-31/3 (Other Identifier)

Details and patient eligibility

About

Bile leakage after liver transection is treated by external drainage. The question addressed is whether downstream control by transpapillary stent insertion into distal bile duct can enhance healing.

Full description

All patients who present with clinically significant bile leakage after liver resection at postoperative day two or longer are offered the opportunity to become randomized to either continuous external drainage or the addition of transpapillary stent.

Enrollment

40 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Liver resection including at least two liver segments.

Exclusion criteria

  • Hepatobiliary digestive anastomosis.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

40 participants in 2 patient groups

Continued external drainage
No Intervention group
Description:
Continued external drainage alone.
Continued external drainage + transpapillary stent
Active Comparator group
Description:
External drainage + transpapillary plastic stent (7-10 Fr).
Treatment:
Device: Transpapillary plastic stent (7-10 Fr)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems